ASGCT 2026

PHILADELPHIA & BOSTON, April 28, 2026 Latus Bio, Inc. has announced new preclinical and computational data supporting its investigational...

WALTHAM, Mass., April 28, 2026 Affinia Therapeutics has announced new progress for AFTX-201, its lead investigational gene therapy for...

CAMBRIDGE, Mass., April 27, 2026 Mirai Bio announced it will unveil two next-generation programs focused on targeted nucleic acid...

CAMBRIDGE, Mass., April 27, 2026 Sail Biomedicines announced it will present new preclinical data supporting its In Vivo eRNA™...

SOUTH SAN FRANCISCO, Calif., April 27, 2026 Encoded Therapeutics announced its participation in the 29th Annual Meeting of the...